Stryker Hip Recall

Hip replacement products are items which come under FDA scrutiny as well. Hip replacement surgery is often carried out in the elderly who develop problems with their hip bones and have trouble moving about. The thigh bone may be capped with a metallic ball for long-lasting effect, and part or the entire pelvis may also be replaced with metallic components to restore normal movement in the individual.

Stryker Corporation is a Michigan-based company which focuses on producing orthopedic products. Founded in 1941, the company has been steadily improving its stand in the global market and commands a higher share of the orthopedic market than its closest competitors. Since the 1990s, the corporation has also been acquiring several smaller orthopedic companies to expand its operations, further strengthening its position in the market. Recently though, a stryker hip recall was issued in light of evidence which pointed out the hazards of Stryker’s products.

Stryker hip recall – the case itself
Stryker Corporation voluntarily issued a recall on its hip replacement products last June after receiving information about the flaws in the product. The friction between the metallic components in the replacements was causing individuals to experience severe discomfort, limited flexibility, and even metal poisoning. In order to rectify these flaws and improve the quality of the product, the Stryker hip replacement recall was issued.

Several individuals across the United States have filed lawsuits against the company, claiming damages and costs of revision surgeries. The products in questions are Stryker’s Rejuvenate and ABG II Modular Neck Hip Stems. If you or someone you know underwent a procedure involving these products, you should consult an orthopedic surgeon immediately in order to determine the integrity of your hip components. Some individuals developed asymptomatic reactions as a result of the replacement surgery, and are eligible to receive compensation as well.

One of the reasons cited for the Stryker hip recall was the lack of thorough testing before the product was launched into the market. Because of its initial promise and the high demand for such a treatment, the products were fast-tracked without undergoing a rigorous vetting process. It was also granted approval by the FDA because of its resemblance to a previously approved product launched by another company. The consequences of the haste are now expected to cost Stryker Corporation up to $390 million.

This is not the first time that a Stryker hip recall has been issued. In 2007, the company issued a voluntary recall of another product called the Trident hip. If you or someone you know who has suffered on account of a faulty product, it may be worth your while consulting a personal injury lawyer specializing in product recall.